Mikhail Telecomlife
9 days ago
kobra fill
20 days ago
choose the best #pet

cats

dogs

ceomagazine
22 days ago
Can I use my Academy Sports Credit Card for gas?

No, you cannot use your Academy card to purchase gas. If you have an Academy credit card, you might be able to use it for gas. Anywhere that takes Mastercard—which includes certain petrol stations—can accept the Academy Sports Credit Card. By conducting an online search or contacting the station directly, you can determine whether a gas station close to you accepts Mastercard. You can also earn rewards on your purchases if you have an Academy credit card, which you can then use to pay for future gas or grocery store trips.
For more details:- https://ceoreviewmagazine.com/finance/academy-sports-credit-card/
Read more
Ramesh Kumar
2 months ago
The Complete Detail on RIMC Exam Preparation Coaching Center
An Overview of the RIMC Exam and Coaching Center ?
The RIMC coaching centre is a professional coaching centre that provides quality coaching services to students preparing for the RIMC's numerous competitive exams.
Mr. Syed Aslam Shah, the center's director, is also a trained coaching instructor with a Bachelor's degree in education and professional coaching accreditation from the World Coaching Foundation.
The following competitive examinations are currently served by the centre:
GATE stands for Graduate Aptitude Test in Engineering.
GAMSAT-Graduate Aptitude Test in Medical Sciences
3. Centralized MBBS-CAMB Admissions Process 4. Centralized Admission Process for Postgraduate Diploma Program - CAMP GMEEI (Graduate Medical Entrance Examination in India) 6. Joint Entrance Exam for Indian Institutes of Technology -
Since its inception in 1996, the RIMC Coaching Centre has provided students with test preparation services. The organisation has a staff of skilled and qualified specialists who are dedicated to providing high-quality services at reasonable prices. During the session, students will receive personalised coaching tutorials to help them better comprehend the material.
It provides comprehensive preparation courses for several competitive tests such as GRE, GMAT, SAT, and IELTS, among others, to help students prepare confidently for these exams.
Full assistance for various student groups such as Indians, Non-Indians, International Students, and Overseas Applicants.
It facilitates students' understanding of competition and culture by organising numerous tours to these countries.
How Do I Select a RIMC Exam Coach?
When selecting a coach, you should consider several factors, including the coaching style, the syllabus, and the charge. You should also evaluate how the coach is perceived by local and international athletes. The coaching style should help you improve as an athlete and achieve your goals.
A powerlifting-style, weightlifting-style, or Olympic weightlifting-style approach are several coaching techniques that are well-known for their success in developing new athletes.
The syllabus should be simple but comprehensive, with enough of materials for you to use and learn from during your session. What was the most crucial thing you did to get ready for your coaching sessions? In order to reach your goals as a coach, you must have a clear focus and direction. It is also critical to understand the goals and how many sessions with each athlete will be required to achieve those goals.
Interviewing coaches is the greatest approach to determine which one is right for you. Inquire about their RIMC exam experience and what they can offer you. You may also inquire about their teaching style and syllabus to get an idea of how long it would take them to assist you prepare for the exam.
It is critical that you select a coach with RIMC exam teaching experience since they will be able to personalise their training to your specific needs. They will also be able to tell you how long it will take them to assist you prepare for your exam.
Choose a coach who is close to you. Depending on your preferences, they will be able to work with you over the phone or in person. Determine how much time you'll need to study for your exam and what kind of training, practise quizzes, and so on you'll require before the exam.
What is a Good Pre-requisite for Enrolling in a Different RIMC Course?
A pre-requisite course is one that you must complete before enrolling in the RIMC programme. The prerequisite courses differ from one school to the next and from one programme to the next. The School of International Studies at AUC offers RIMC courses. Courses at RIMC RIMC 101: Introduction to International Studies- This course will not be offered in 2022-23. 201: International Studies Overview RIMC 203: International Relations History As an academic discipline, Asian studies is the broad study of Asia. Asian studies is an intellectual activity or field that studies Asia as a whole. It is divided into several subfields and techniques.
People must complete a number of prerequisite courses before they can even consider taking the RIMC test. A excellent example is the business English course, which is required for many English degree programmes and colleges. How much does a radiation therapy graduate certificate cost in total? The overall cost of the programme varies depending on the number of credits you take.
https://asianschooleducation.com/rimc-coaching-in-india
https://78.46.200.66/u5zFGpGU9toMXH7Fn6Sx
https://www.beqbe.com/the-complete-information-on-the-best-rim
https://carbonfacesocial.org/blogs/11057/All-Details-About-on-RIMC-Coaching-Centre
https://www.chat-hozn3.com/blogs/77460/The-Complete-Detail-on-best-coaching-centre-for-rimc-in
https://chatoroom.com/blogs/1297/The-Complete-Information-on-best-coaching-centre-for-rimc-in
https://www.cienciared.es/blogs/15588/The-Complete-Structure-on-best-coaching-centre-for-rimc-in
https://clubnudista.com/read-blog/6384
Read more
Mikhail Telecomlife
4 months ago
Parviz Sharipov
5 months ago
We create design that actually works.
Design for your project will help you stand out from competitors, gain the trust of customers and partners.
https://www.mansurtl.com/home
demoworker
7 months ago
A diferencia de muchos competidores en la industria de creación de logotipos, no le cobraremos todos los meses. Solo le cobraremos una tarifa única y el logotipo será suyo para siempre. Sin costes adicionales en el futuro.
Read more
Anime Music
10 months ago
vhello-peter
hello-peter
hello-peter
hello-peter
Anime Music
10 months ago
Test Guy
10 months ago
Lucas Luke
11 months ago
Hey ! Petit test :)
topsignaljammer top
11 months ago
Airport: In recent years, drones "flying black", especially the incidents of invading the airport clearance protection area, have frequently occurred, seriously threatening the normal operation of the airport and the safety of passengers.

Important event sites: conference sites, such as large international conferences, major home diplomatic events, sports competitions

Wireless Remote Control Portable Drone Blocker GPS Frequency
Prisons: Prisons have high privacy to prevent information leakage

Military Administrative Areas: Article 15 of the Law on the Protection of Military Facilities prohibits personnel, vehicles and ships from entering the military restricted areas other than the management units of land and water military restricted areas, and prohibits photography, video recording, recording, surveying, surveying, depicting and describing the military restricted areas. Aircraft are prohibited from flying at low altitudes over military restricted areas. However, unless approved by military organs at or above the military region level

Large-scale concerts: Large-scale concerts are one of the most crowded places, and one of the security plans will have security measures to prevent drones from intruding.

Drone jammer can prevent drones from taking pictures, control or force drones to land.

https://topsignaljammer.com/
Read more
Steffan Joe
11 months ago
Site management organizations (SMO) market is projected to grow at an annualized rate of ~10% during the period 2021-2035.
In addition to being a time and cost intensive process, clinical trials are fraught with several challenges; considering the expertise available with site management organizations (SMOs) to conduct such studies in an efficient manner, trial sponsors are actively outsourcing their requirements

Roots Analysis is pleased to announce the publication of its recent study, titled, “Site Management Organizations (SMO) Market, 2021–2035.”

The study features an in-depth analysis, highlighting the capabilities of clinical trial site management service providers engaged in this domain. Amongst other elements, the report features:
 A detailed assessment of the current market landscape of companies offering clinical trial site management services.
 A competitiveness analysis of various service providers segregated into three peer groups based on location of their headquarters (North America, Europe, and Asia-Pacific and RoW). The companies were further distributed across the geographies, based on their employee count, into three categories, namely small (500 employees).
 Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) that offer various clinical trial site management services, across North America, Europe and Asia-Pacific.
 An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2016-2021 (till August).
 A detailed analysis of various investments received by players engaged in this domain during the period 2015-2021 (till August).
 An in-depth analysis of completed, ongoing and planned clinical studies during the period 2016-2021 (till August).
 An informed estimate of the annual demand for clinical study participants, based on various relevant parameters, for the period 2021-2035.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
 Therapeutic Areas
 Oncological Disorders
 CNS Disorders
 Infectious Diseases
 Respiratory Disorders
 Cardiovascular Diseases
 Endocrine Disorders
 Gastrointestinal Disorders
 Musculoskeletal Diseases
 Immunological Disorders
 Others

 Trial Phases
 Phase I
 Phase II
 Phase III
 Phase IV

 Clinical Trial Components
 Site Management
 Onsite Monitoring
 Project Management
 Data Management
 Regulatory Affairs
 Logistics
 Quality Control
 Others

 Types of Interventions
 Therapeutics
 Devices
 Surgical Procedure

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 MENA
 Rest of the World

 Transcripts of interviews held with the following senior level representatives of stakeholder companies
 Vinod Gyanchandani (Country Head - Clinical Operations, GDD Experts)
 Marisa Vico (Medical Director and Operations Manager, SMO – Dra. Marisa Vico)
 Eugene Winifred (Project Manager, Syncretic Clinical Research Services)

Key companies covered in the report
 FOMAT Medical Research
 Parexel
 Pharm-Olam
 Veristat
 WCCT Global
 Worldwide Clinical Trials
 CROMSOURCE
 Fidelis Research
 Scandinavian CRO
 TFS HealthScience
 Trialbee
 CMIC
 George Clinical
 Tigermed
 Veeda Clinical Research

For more information, please click on the following link:
https://www.rootsanalysis.com/reports/site-management-organizations-market.html

You may also be interested in the following titles:
1. Patient Recruitment and Retention Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030
2. Pharmaceutical Contract Research Services Market: Industry Trends and Global Forecasts, 2021-2030
3. Clinical Trial Planning and Design Services Market: Industry Trends and Global Forecasts, 2021-2030
4. Biospecimen Contract Research Services Market: Industry Trends and Global Forecast, 2021-2030
5. Biologics Fill / Finish Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at inforootsanalysis.com

Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnsonrootsanalysis.com
Read more
Steffan Joe
11 months ago
The RNA targeting small molecules therapeutics market is estimated to be worth USD 8.3 billion in 2030.

In recent years, RNA’s potential as a target molecule for small molecules has been widely recognized; a number of players have developed proprietary technologies for direct and indirect RNA targeting, to treat a wide range of clinical conditions

Roots Analysis is pleased to announce the publication of its recent study, titled, “RNA Targeting Small Molecules Therapeutics Market”

The report features an extensive study of the current market landscape and future potential of the players engaged in the discovery and development of RNA targeting small molecules therapeutics. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:

 An in-depth review of the market landscape of players that are engaged in the discovery and development of RNA targeting small molecules therapeutics being evaluated at both preclinical and clinical stages of development. It also includes a detailed landscape of developers active in this domain.
 An insightful analysis of the company competitiveness and investment landscape comparing the key players engaged in the domain of RNA targeting small molecules. Further, it includes start-ups and investment activity across different players.
 An analysis of the partnerships that have been inked by stakeholders in this area, during the period between 2017 and 2021.
 An in-depth analysis of investments made, during the period between 2015 and 2021, in companies that are engaged in the development of RNA targeting small molecules therapeutics.
 Elaborate profiles of key players engaged in the development of RNA targeting small molecules therapeutics.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

 Type of Target Disease Indication
 Aniridia
 Breast Cancer
 Castrate-resistant Prostate Cancer
 Colorectal Cancer
 Cystic Fibrosis
 Crohn’s Disease
 Duchenne Muscular Dystrophy
 Dravet Syndrome
 HIV Infections
 Impaired Renal Function
 NSCLC
 Rheumatoid Arthritis
 Spinal Muscular Atrophy
 Ulcerative Colitis

 Type of Therapeutic Area
 Autoimmune Disorders
 Genetic Disorders
 Inflammatory Disorders
 Infectious Disorders
 Kidney Disorders
 Neurological Disorders
 Oncological Disorders
 Ophthalmic Disorders
 Rare Disorders
 Respiratory Disorders

 Type of Target Molecule
 CDKL5
 Cap Binding Complex
 Dystrophin Protein
 Estrogen Receptor Alpha
 G542X
 MNK1 / MNK2
 PAX6 Gene
 SMN2

 Type of Approach
 Indirect RNA Targeting- Epitranscriptomics
 mRNA Translation Modulation
 RNA Splicing Modification

 Route of Administration
 Oral
 Subcutaneous

 Key Geographical Regions
 North America
 Europe

Transcripts of interviews held with the following senior level representatives of stakeholder companies
 Clara Assouline (Business Development, Anima Biotech)
 Dominique Cheneval (Co-Founder and Chief Executive Officer, Novation Pharmaceuticals)

Key companies covered in the report
 Abivax
 AC Immune
 Arrakis Therapeutics
 eFFECTOR Therapeutics
 ELOXX Pharmaceuticals
 PTC Therapeutics
 H3 Biomedicine
 Ribometrix
 Skyhawk Therapeutics
 STORM Therapeutics

For more information, please click on the following link
https://www.rootsanalysis.com/reports/rna-targeting-small-molecule-therapeutics-market.html

Other Recent Offerings
1. RAS Targeting Therapies: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2030
2. DNA Damage Response Targeting Therapeutics: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2030
3. HER2 Targeting Therapies: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2030

Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnsonrootsanalysis.com
Read more
Mason Joe
12 months ago
Cell and Gene Therapy Bioassay Services Market by Type of Therapy, Industry Trends and Global Forecasts, 2021-2030.

Roots Analysis has announced the addition of Cell and Gene Therapy Bioassay Services Market report to its list of offerings.

During our research, we were able to capture more than 40 players, which claims to offer bioassay services related for cell and gene therapies.

Amongst the total players offering bioassay services for cell and gene therapies, most of the players engaged in this domain were established before 1995. Of these, nine are headquartered in North America, while eight are based in Europe. Further, the industry witnessed the establishment of nine players, post 2010. Of these, five are based in North America, three in Europe and one in the Asia-Pacific region. In addition to this, all of the bioassay service providers (100%) are offering pre-developed assay. This is followed by 89% players that offer customized assays for cell and gene therapies.

To request a sample copy / brochure of this report, please visit this - https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market/request-sample.html

Scope of the Report –

The “Cell and Gene Therapy Bioassay Services Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological Disorders, Infectious Diseases, Autoimmune Disorders, Rare / Genetic Disorders, Cardiovascular Disorders, Metabolic Disorders, Blood Disorders, Neurological Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2030” report features an extensive study of the current landscape and the likely future potential of cell and gene therapy bioassay service providers, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. In addition to other elements, the study includes:
 A detailed assessment of the overall market landscape of the cell and gene therapy bioassay services market, providing information on their year of establishment, company size, location of headquarters, location of bioanalytical facilities, type of offering (in vitro and in vivo), type of bioassay(s) offered (pre-developed assay and customized assay), type of bioanalytical services (immunoassay, potency assay, qualitative PCR, digital droplet PCR, flow cytometry, ELISA, immunochemistry and others) and application area (cell therapy, gene therapy and others).
 A detailed competitiveness analysis of the cell and gene therapy bioassay service providers based in different geographies, by taking into consideration their service strength (in terms of bioassay offering(s) and number of bioanalytical services offered), service applicability (in terms of number of bioassays offered and application area) and supplier strength (in terms of years of experience in this field and company size).
 Tabulated profiles of key players offering a wide range of cell and gene therapy bioassay services across North America, Europe and Asia-Pacific. Each profile includes an overview of the company, financial information (if available), details of its cell and gene therapy bioassay services portfolio, types of offerings, type of bioassay(s) offered, types of bioanalytical services offered, application area, location of bioanalytical facilities, recent developments and an informed future outlook.
 An insightful contemporary market trend analysis, featuring the distribution of cell and gene therapy service providers by type of bioanalytical services offered and application area and an analysis of cell and gene therapy service providers, based on type of bioassay and types of bioanalytical services offered. Further, the chapter also features a schematic world map representation, highlighting the location of bioanalytical facilities of cell and gene therapy bioassay service providers.
 A detailed analysis of the global events attended by the service providers, based on year of event, type of event, type of services involved and application area, and strategic initiatives taken by various cell and gene therapy bioassay service providers.
 A case study of the overall landscape of cell and gene therapy therapeutics market, based on a number of parameters. The market landscape of cell therapies, features distribution of cell therapies across phase of development, therapeutic area and type of developer. Further, the market landscape of cell therapies, features distribution of gene therapies across phase of development of pipeline candidates and key therapeutic areas. The chapter also features information on the developers involved in the domain of cell and gene therapies.
 An in-depth analysis of more than 260 cell therapy developers that are anticipated to partner with cell and gene therapy bioassay service providers and have been shortlisted on the basis of several relevant parameters, such as developer strength (which takes into account a company’s size and its experience in this field), pipeline strength and maturity (based on the number of pipeline drugs and affiliated stage of development) and availability of other cell therapy capabilities.

To request a free insight to this report – https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market/free-insights.html

Majority of the service providers (56%) have established their facilities in North America; within this region, most of the facilities are located in US (97%), followed by Canada (3%). Further, close to 40% players have their manufacturing facilities in Europe, while the remaining have established their facilities in Asia-Pacific and rest of the world (~10%). It is worth highlighting that, in Asia-Pacific, majority of the service providers ha
Read more
Michael Doe
12 months ago
The globe claim to provide contract fill / finish services for various types of biopharmaceutical drug / therapy products.

Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations. Consequently, a number of drug manufacturers have demonstrated a preference for outsourcing fill / finish operations of such products.

To order this 480+ page report, which features 350+ figures and 260+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

The USD 4.2 billion (by 2030) financial opportunity within the biologics fill / finish services market has been analyzed across the following segments:
 Types of Primary Packaging Containers
 Ampoules
 Cartridges
 Syringes
 Vials

 Types of Biologics
 Peptides / proteins
 Antibodies
 Vaccines
 Cell therapies
 Gene therapies
 Viral products
 Oligonucleotides
 Others

 Company Size
 Small-sized
 Mid-sized
 Large / very large

 Scale of Operation
 Preclinical
 Clinical
 Commercial

 Key Therapeutic Areas
 Cancer
 Infectious diseases
 Autoimmune diseases
 Cardiovascular diseases
 Other indications

 Key Geographical Regions
 North America (US, Canada)
 Europe (UK, France, Germany, Italy, Spain and rest of the Europe)
 Asia-Pacific (Japan, China, South Korea, India and Australia)

The Biologics Fill / Finish Services Market, 2019-2030.”report features the following companies, which we identified to be key players in this domain:
 Advanced BioScience Laboratories (ABL)
 Albany Molecular Research (AMRI)
 Biocon
 BioPharma Solutions
 BioReliance
 Boehringer Ingelheim BioXcellence
 ChemPartner
 Emergent BioSolutions
 IDT Biologika
 Lonza
 LuinaBio
 Mycenax Biotech
 Patheon
 Recipharm
 Vetter Pharma
 WuXi Biologics

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Competitive Landscape

5. Company Competitiveness Analysis

6. Biologics Fill / Finish Service Providers in North America: Company Profiles

7. Biologics Fill / Finish Service Providers in Europe: Company Profiles

8. Biologics Fill / Finish Service Providers in Asia-Pacific: Company Profiles

9. Partnerships and Collaborations

10. Recent Expansions

11. Capacity Analysis

12. Demand Analysis

13. Biologics Manufacturing and Fill / Finish: Key Performance Indicator Analysis

14. Market Sizing and Opportunity Analysis

15. Future Growth Opportunities

16. Case Study: Robotic Systems in Fill / Finish Operations

17. Case Study: Ready-to-Use Packaging Components in Aseptic Fill / Finish Operations

18. Conclusion

19. Interview Transcripts

20. Appendix 1: Tabulated Data

21. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at inforootsanalysis.com

Contact Details
Ben Johnson
+1 (415) 800 3415
ben.johnsonrootsanalysis.com

Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
Read more
Michael Doe
12 months ago
Clinical Trial Planning and Design Services Market by Phase of Trial, Industry Trends and Global Forecasts, 2021-2030.

Roots Analysis has announced the addition of Clinical Trial Planning and Design Services Market report to its list of offerings.

During our research, we were able to identify 46 industry players that are engaged in offering clinical trial planning and design services. The clinical trial planning and design services domain is presently dominated by the presence of large firms (70%), followed by mid-sized companies (18%). most of the players engaged in this domain offer study design / protocol development (96%), followed by those providing sample size and power analysis services (83%). Notable examples of players offering more than four services include (in alphabetical order), Cancer Research And Biostatistics (1997), Peter MacCallum Cancer Centre (1949), Singapore Clinical Research Institute (2008) and University of Arizona College of Medicine (2006).

To request a sample copy / brochure of this report, please visit this – https://www.rootsanalysis.com/reports/clinical-trial-planning-and-design-services-market/request-sample.html

Over the years, clinical research has undergone an evolutionary change, in terms of cost of research, technology used, and duration of the study. Clinical research involves a thorough literature review that helps to collate information on studies that involve interactions with patients and diagnostic clinical trial data, in order to understand the root cause of a disease and its treatment. It is worth highlighting that clinical research involves two major steps, namely study design and study reporting. Further, study design involves three key steps, theoretical design, data collection design and statistical analysis design. Specifically, experimental or non-experimental data collection, sampling or census data collection, and temporal characteristics of the variables to be examined are all aspects of data collection design. On the other hand, study reporting includes guiding principles to carry out concise, explicit and elaborative research.

 Planning Period: This parameter takes into consideration the time period that is required to draw up the protocol, as well as to define the objectives of the trial. It is worth highlighting that the period for planning a clinical trial can take up to a year.
 Duration of a Trial: It takes into consideration the amount of time required to recruit participants, as well as to monitor their reaction and survival rate.
 Comparability of Patients: It takes into consideration the comparability of enrolled patient population with respect to prognostic factors. It is worth mentioning that prognostic factors define the enrolled patient population, help to formulate the objectives of the trial, and provide better treatment strategies. These factors provide valid estimates of the differences in the given treatment and help to evaluate results across different studies.
 Treatment Allocation Ratio: This step helps to reduce bias, balanced comparison between two treatment groups and quantification of errors. It is worth highlighting that patients can be allocated to two different trials at the same time; however, in such cases, patients are usually allocated randomly in a 60:40 or 2:1 ratio.
 Use of Historical Control Group: Historical control group can be used to estimate model parameters during the research design phase, to modify a study, or to augment or replace a control arm. Most of the clinical trials include a control group of patients who have the same characteristics as the specially treated group; however, these patients are not administered with the drug / therapy treatment.
 Treatment Management: The treatment provided to enrolled patients should be administered equally, regardless of their treatment plan. Further, in each therapy group, patients should have the same criteria of response and toxicity.
 Ethical Considerations: Ethical concerns can arise at any point throughout the trial. It is worth mentioning that conditions under which a patient may be withdrawn from the study should be carefully examined, prior to the trial. Further, an international review board must approve all human-related research projects.

To request a free insight to this report - https://www.rootsanalysis.com/reports/clinical-trial-planning-and-design-services-market/free-insights.html

Key Questions Answered
 Who are the key players engaged in offering clinical trial planning and design services, across the world?
 What are the regulatory guidelines established in different geographies and their requirements related to clinical trial planning and design?
 What kind of partnership models are most commonly adopted by stakeholders engaged in this industry?
 What are the key value drivers of the merger and acquisition activity observed within this domain?
 How is the current and future market opportunity likely to be distributed across key market segments?
 What are the anticipated future trends related to clinical trial planning and design services?

For additional details, please visit - https://www.rootsanalysis.com/reports/clinical-trial-planning-and-design-services-market.html Or salesrootsanalysis.com

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at inforootsanalysis.com

Contact Details
Ben Johnson
+1 (415) 800 3415
ben.johnsonrootsanalysis.com

Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Read more
Steffan Joe
12 months ago
PRE-STERILIZED / READY-TO-USE PRIMARY PACKAGING MARKET - CURRENT MARKET LANDSCAPE

Roots Analysis has announced the addition of Pre-Sterilized / Ready-to-Use Primary Packaging Market report to its list of offerings.

Presently, more than 150 pre-sterilized / RTU primary packaging systems, including cartridges, syringes and vials, as well as their respective closure systems are available worldwide. Majority (50%) of the pre-sterilized / RTU primary packaging systems are closures, followed by containers (34%) and container-closure systems (16%). It is worth highlighting that, of the total, 54 closures are suitable for use with vials, 19 are suitable for use with syringes and the remaining 5 are compatible with cartridges.

To request a sample copy / brochure of this report, please visit this – https://www.rootsanalysis.com/reports/224/request-sample.html

Amongst the primary packaging containers, vials and syringes emerged as the most common types of pre-sterilized / RTU containers manufactured by stakeholders engaged in this domain. This can be attributed to the fact that these containers are the most suitable for packaging of small volume of therapeutics, such as biologics, cell therapies, small molecules, vaccines and other potent products.

Scope of the Report: -

The “Pre-Sterilized / Ready-to-Use Primary Packaging: Focus on Cartridges, Syringes and Vials (2nd Edition) - Market Distribution by Type of Packaging System (Vials, Syringes, Cartridges and Closures), Packaging Material (Glass and Plastic) and Key Geography (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa and Rest of the World) – Global Forecast 2021-2030” report features an extensive study of the current market landscape and future potential of ready-to-use primary packaging components, including cartridges, syringes and vials, and their respective closure systems (such as stoppers, needle shields and plungers) over the next decade. The study features an in-depth analysis of the key drivers and trends related to this domain. Amongst other elements, the report includes:
 A detailed assessment of the current market landscape of ready-to-use primary packaging components, featuring information on the type of container (vials, syringes, cartridges and others), type of fabrication material used (glass and plastic), sterilization technique used (ethylene oxide sterilization, steam sterilization, gamma irradiation, electron beam sterilization and dry heat sterilization), volume of container (less than 50 ml, 50 ml to 100 ml and more than 100 ml), compatible drug class (biologics and small molecules) and type of closure (stoppers, plungers, tip caps / needle shields, caps and seals). In addition, the chapter includes details related to ready-to-use packaging system manufacturers, along with information on their respective year of establishment, company size, location of headquarters and key players (in terms of number of offerings).
 A competitiveness analysis of ready-to-use primary packaging system manufacturers based on various relevant parameters, such as supplier power (based on the experience / expertise of the manufacturer) and key product specifications (type of container, type of fabrication material used, type of closure, sterilization technique used and compatible drug class).
 Elaborate profiles of prominent players engaged in the development of ready-to-use primary packaging systems. Each profile features a brief overview of the company, details related to its financials (if available), product portfolio, recent developments and an informed future outlook.
 An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2015-2021, covering acquisitions, product / technology integration agreements, supply agreements, product / technology licensing agreements, product / technology development agreements, service alliances, distribution agreements and other relevant types of deals.
 An insightful discussion on the impact of the recent COVID-19 pandemic on the businesses of primary pharmaceutical packaging manufacturers. In addition, we have provided information on the strategic initiatives undertaken by pharmaceutical players to mitigate the challenges affiliated with the current global crisis.
 An in-depth analysis to estimate the current and future demand for ready-to-use container-closure systems based on various relevant parameters, such as type of packaging system and type of fabrication material used, across different regions, for the period 2021-2030.
 An elaborate discussion on the key trends (such as the advent of personalized / targeted therapies, shift towards more flexible packaging, rise of modular manufacturing facilities and advancement in robotic packaging solutions) that are likely to have an impact on the future adoption of ready-to-use packaging systems. It also features a Harvey ball analysis, highlighting the relative effect of each trend on the overall pharmaceutical packaging industry.
 A case study on the use of robotic machinery in pharmaceutical manufacturing and fill / finish operations, highlighting the advantages of using automation / automated technologies in such processes. Further, it presents the profiles of industry players that provide such equipment for aseptic processing of pharmaceuticals.

Key Questions Answered
 Who are the prominent players engaged in the global pre-sterilized / ready-to-use primary packaging market?
 What is the relative competitiveness of different ready-to-use primary packaging system manufacturers?
 Which partnership models are most commonly adopted by stakeholders engaged in this industry?
 How is the recent COVID-19 pandemic likely to impact the global ready-to-use primary packaging systems market?
 What is the current, global demand for ready-to-use containers and closures?
 What are the major market trends and driving factors that are
Read more
Mason Joe
12 months ago
The RNA targeting small molecules therapeutics market predicts Roots Analysis
In recent years, RNA’s potential as a target molecule for small molecules has been widely recognized; a number of players have developed proprietary technologies for direct and indirect RNA targeting, to treat a wide range of clinical conditions

Roots Analysis is pleased to announce the publication of its recent study, titled, “RNA Targeting Small Molecules Therapeutics Market”

The report features an extensive study of the current market landscape and future potential of the players engaged in the discovery and development of RNA targeting small molecules therapeutics. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:

 An in-depth review of the market landscape of players that are engaged in the discovery and development of RNA targeting small molecules therapeutics being evaluated at both preclinical and clinical stages of development. It also includes a detailed landscape of developers active in this domain.
 An insightful analysis of the company competitiveness and investment landscape comparing the key players engaged in the domain of RNA targeting small molecules. Further, it includes start-ups and investment activity across different players.
 An analysis of the partnerships that have been inked by stakeholders in this area, during the period between 2017 and 2021.
 An in-depth analysis of investments made, during the period between 2015 and 2021, in companies that are engaged in the development of RNA targeting small molecules therapeutics.
 Elaborate profiles of key players engaged in the development of RNA targeting small molecules therapeutics.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

 Type of Target Disease Indication
 Aniridia
 Breast Cancer
 Castrate-resistant Prostate Cancer
 Colorectal Cancer
 Cystic Fibrosis
 Crohn’s Disease
 Duchenne Muscular Dystrophy
 Dravet Syndrome
 HIV Infections
 Impaired Renal Function
 NSCLC
 Rheumatoid Arthritis
 Spinal Muscular Atrophy
 Ulcerative Colitis

 Type of Therapeutic Area
 Autoimmune Disorders
 Genetic Disorders
 Inflammatory Disorders
 Infectious Disorders
 Kidney Disorders
 Neurological Disorders
 Oncological Disorders
 Ophthalmic Disorders
 Rare Disorders
 Respiratory Disorders

 Type of Target Molecule
 CDKL5
 Cap Binding Complex
 Dystrophin Protein
 Estrogen Receptor Alpha
 G542X
 MNK1 / MNK2
 PAX6 Gene
 SMN2

 Type of Approach
 Indirect RNA Targeting- Epitranscriptomics
 mRNA Translation Modulation
 RNA Splicing Modification

 Route of Administration
 Oral
 Subcutaneous

 Key Geographical Regions
 North America
 Europe

To request a sample copy / brochure of this report, please visit this – https://www.rootsanalysis.com/reports/rna-targeting-small-molecule-therapeutics-market/request-sample.html

Transcripts of interviews held with the following senior level representatives of stakeholder companies
 Clara Assouline (Business Development, Anima Biotech)
 Dominique Cheneval (Co-Founder and Chief Executive Officer, Novation Pharmaceuticals)

Key companies covered in the report
 Abivax
 AC Immune
 Arrakis Therapeutics
 eFFECTOR Therapeutics
 ELOXX Pharmaceuticals
 PTC Therapeutics
 H3 Biomedicine
 Ribometrix
 Skyhawk Therapeutics
 STORM Therapeutics

For more information, please click on the following link
https://www.rootsanalysis.com/reports/rna-targeting-small-molecule-therapeutics-market.html

Other Recent Offerings
1. RAS Targeting Therapies: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2030
2. DNA Damage Response Targeting Therapeutics: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2030
3. HER2 Targeting Therapies: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2030

Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnsonrootsanalysis.com
Read more
Mason Joe
12 months ago
The site management organizations (SMO) market, claims Roots Analysis

In addition to being a time and cost intensive process, clinical trials are fraught with several challenges; considering the expertise available with site management organizations (SMOs) to conduct such studies in an efficient manner, trial sponsors are actively outsourcing their requirements

Roots Analysis is pleased to announce the publication of its recent study, titled, “Site Management Organizations (SMO) Market, 2021–2035.”

To request a sample copy / brochure of this report, please visit this – https://www.rootsanalysis.com/reports/site-management-organizations-market/request-sample.html

The study features an in-depth analysis, highlighting the capabilities of clinical trial site management service providers engaged in this domain. Amongst other elements, the report features:

A detailed assessment of the current market landscape of companies offering clinical trial site management services.
A competitiveness analysis of various service providers segregated into three peer groups based on location of their headquarters (North America, Europe, and Asia-Pacific and RoW). The companies were further distributed across the geographies, based on their employee count, into three categories, namely small (500 employees).
Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) that offer various clinical trial site management services, across North America, Europe and Asia-Pacific.
An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2016-2021 (till August).
A detailed analysis of various investments received by players engaged in this domain during the period 2015-2021 (till August).
An in-depth analysis of completed, ongoing and planned clinical studies during the period 2016-2021 (till August).
An informed estimate of the annual demand for clinical study participants, based on various relevant parameters, for the period 2021-2035.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
Therapeutic Areas
Oncological Disorders
CNS Disorders
Infectious Diseases
Respiratory Disorders
Cardiovascular Diseases
Endocrine Disorders
Gastrointestinal Disorders
Musculoskeletal Diseases
Immunological Disorders
Others

Trial Phases
Phase I
Phase II
Phase III
Phase IV

Clinical Trial Components
Site Management
Onsite Monitoring
Project Management
Data Management
Regulatory Affairs
Logistics
Quality Control
Others

Types of Interventions
Therapeutics
Devices
Surgical Procedure

Key Geographical Regions
North America
Europe
Asia-Pacific
Latin America
MENA
Rest of the World

Transcripts of interviews held with the following senior level representatives of stakeholder companies
Vinod Gyanchandani (Country Head - Clinical Operations, GDD Experts)
Marisa Vico (Medical Director and Operations Manager, SMO – Dra. Marisa Vico)
Eugene Winifred (Project Manager, Syncretic Clinical Research Services)

Key companies covered in the report

FOMAT Medical Research
Parexel
Pharm-Olam
Veristat
WCCT Global
Worldwide Clinical Trials
CROMSOURCE
Fidelis Research
Scandinavian CRO
TFS HealthScience
Trialbee
CMIC
George Clinical
Tigermed
Veeda Clinical Research

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/site-management-organizations-market.html

You may also be interested in the following titles:

Patient Recruitment and Retention Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030
Pharmaceutical Contract Research Services Market: Industry Trends and Global Forecasts, 2021-2030
Clinical Trial Planning and Design Services Market: Industry Trends and Global Forecasts, 2021-2030
Biospecimen Contract Research Services Market: Industry Trends and Global Forecast, 2021-2030
Biologics Fill / Finish Services Market (2nd Edition): Industry Trends and Global Forecasts, 2021-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at inforootsanalysis.com

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnsonrootsanalysis.com
Read more
Michael Doe
12 months ago
The oligonucleotide synthesis, modification and purification services market is estimated to grow at a CAGR of 18%, till 2030, predicts Roots Analysis
The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to the complexities associated with the synthesis and processing of these molecules, such operations are usually outsourced to capable CMOs

Roots Analysis is pleased to announce the publication of its recent study, titled, “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2021-2030.”

To request a sample copy / brochure of this report, please visit this – https://www.rootsanalysis.com/reports/oligonucleotide-synthesis/request-sample.html

The report features a detailed study of the current scenario and future potential of the custom synthesis, modification and purification services market for oligonucleotides, which are intended for research, diagnostic, and therapeutic applications. Further, the study underlines an in-depth analysis, highlighting the capabilities of service providers engaged in this domain. In addition to other elements, the study covers:
 A detailed assessment of the current market landscape of oligonucleotide manufacturers focused on research and diagnostic and therapeutic applications.
 An insightful company competitiveness analysis, highlighting the key oligonucleotide manufacturers focused on research and diagnostic, and therapeutic applications, based on supplier strength and service strength.
 Elaborate profiles of key players engaged in offering custom synthesis, modification and purification of oligonucleotides for research and diagnostic, and therapeutic applications.
 A qualitative analysis highlighting the various factors that need to be considered by players engaged in this domain, while deciding whether to manufacture their respective products in-house or engage the services of a service provider.
 A detailed review of the various oligonucleotide-based manufacturing initiatives undertaken by big pharma players (on the basis of revenues generated by top 5 pharmaceutical companies in 2020).
 An analysis of recent partnerships inked between players engaged in oligonucleotide manufacturing, during the period 2014-2021.
 An analysis of the various expansion initiatives undertaken by service providers engaged in this domain, during the period 2016-2021.
 An in-depth analysis of over 90 oligonucleotide-based therapy developers that are likely to partner with contract service providers engaged in this domain.
 A detailed analysis of more than 440 completed and ongoing clinical research studies of various oligonucleotide-based drugs.
 An estimate of the global, installed capacity for the manufacturing of oligonucleotides, based on information provided by various industry stakeholders in the public domain.
 An informed estimate of the annual commercial demand for oligonucleotide-based drugs (in kilograms).
 An elaborate discussion on how the recent COVID-19 pandemic is likely to impact the oligonucleotide synthesis market, along with information on the key initiatives undertaken by players engaged in this domain to overcome the challenges faced due to the pandemic.
 A discussion on affiliated trends, key drivers and challenges, under an elaborate SWOT framework, which are likely to impact the industry’s evolution, including a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall industry.
 A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing custom synthesis, modification and purification services for oligonucleotides.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Application Area
 Research and Diagnostic Applications
 Therapeutic Applications

 Type of Oligonucleotide
 Antisense Oligonucleotides
 miRNA
 shRNA
 siRNA
 Others

 Scale of Operation
 Clinical
 Commercial

 Purpose of Production
 In-house Operations
 Outsourced Operations

 Type of Operation
 API
 FDF

 Size of Manufacturer
 Small
 Mid-sized
 Large

 Key Therapeutic Areas
 Autoimmune Disorders
 Cardiovascular Disorders
 Genetic Disorders
 Infectious Diseases
 Metabolic Disorders
 Neuromuscular Disorders
 Oncological Disorders
 Ophthalmic Disorders
 Other Therapeutic Areas

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific and the Rest of the World

Key companies covered in the report
 Agilent Technologies
 Ajinomoto Bio-Pharma Services
 BioSpring
 CordenPharma
 Integrated DNA Technologies
 Kaneka Eurogentec
 LGC Biosearch Technologies
 Lonza
 Microsynth
 Nitto Denko Avecia
 Sigma Aldrich
 STA Pharmaceutical
 Sumitomo Chemical
 Thermo Fisher Scientific
 TriLink Biotechnologies
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html

Other Recent Offerings
1. Pharmaceutical Contract Manufacturing Market (3rd Edition), 2021-2030
2. Biopharmaceutical Contract Manufacturing Market (4th Edition), 2021-2030
3. Antisense Oligonucleotide Therapeutics Market, 2020-2030
4. RNAi Therapeutics Market (2nd Edition), 2019 - 2030

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at inforootsanalysis.com

Contact Information
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.joh
Read more
Michael Doe
12 months ago
The Protein design and engineering services market is likely to grow at CAGR of over 14% during the period 2021-2035.
In addition to being a time and cost intensive process, protein engineering market is fraught with several challenges; considering the expertise available with protein design and engineering service providers to design novel molecules, drug developers are actively outsourcing their requirements

Roots Analysis is pleased to announce the publication of its recent study, titled, “Protein Design and Engineering Market, 2021–2035.”

To request a sample copy / brochure of this report, please visit this - https://www.rootsanalysis.com/reports/protein-design-and-engineering-market/request-sample.html

The study features an in-depth analysis, highlighting the capabilities of protein design and engineering technology and service providers. Amongst other elements, the report features:
 A detailed assessment of the current market landscape of companies offering protein design and engineering services.
 A competitiveness analysis of various service providers segregated into three peer groups based on their employee count, into three categories, namely small (500 employees).
 Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) that offer various protein design and engineering services, across North America, Europe and Asia Pacific.
 A detailed assessment of the current market landscape of protein design and engineering technology providers
 An insightful 2×2 matrix representation of the competitiveness analysis of various protein design and engineering technologies segregated into two peer groups based on the company size of their respective technology provider, namely small (1-50 employees) and mid-sized companies (51-500 employees).
 Elaborate profiles of key players (shortlisted based on a proprietary criterion) that are engaged in offering technologies for protein design and engineering.
 An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2017-2021 (till September).
 A detailed analysis of over 130 protein / peptide based therapy developers that are likely to partner with protein design and engineering services and technology providers.
 An in-depth analysis of the various patents that have been filed / granted related to protein design and engineering market, during the period 2019 to 2021 (till September)
 An in-depth analysis of completed, ongoing and planned clinical studies of various protein / peptide based therapies during the period 2016-2021 (till September).
 A case study presenting the key characteristics of novel peptide therapeutics, along with information on their applications and advantages, as well as key challenges associated with their development process.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
 Type of Protein Engineering Approach Used
 Rational Designing
 Directed Evolution
 Semi - Rational Designing

 Type of Protein
 Antibodies
 Peptides
 Enzymes
 Vaccines
 Others

 Type of Application
 Therapeutics
 Diagnostics

 Types of End User
 Pharma / Biotech Firms
 CROs
 Research / Academic Institutes

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 MENA
 Rest of the World

 Transcripts of interviews held with the following senior level representatives of stakeholder companies
 Roman Badik (Chief Executive Officer, Enantis)
 Haibin Chen (Vice President - R&D, Enzymaster)
 Naveen Kulkarni (Chief Executive Officer, Quantumzyme)

Key companies covered in the report
 ATUM
 Creative BioMart
 Creative Biostructure
 Creative Enzymes
 Absolute Antibody
 EUCODIS Bioscience
 Fusion Antibodies
 Innovagen AB
 Zymvol Biomodeling
 Averin Biotech
 EnzymeWorks
 GeNext Genomics
 Quantumzyme
 Arzeda
 Cyrus Biotechnology
 Enzymaster
 Innovative Targeting Solutions
 Proteus by Seqens

For more information, please click on the following link:
https://www.rootsanalysis.com/reports/protein-design-and-engineering-market.html

You may also be interested in the following titles:
1. ADC Cytotoxic Payloads / Warheads Market: Products and Services Market: Industry Trends and Global Forecasts, 2021-2035
2. Site Management Organizations (SMO) Market: Industry Trends and Global Forecasts, 2021-2035
3. Glycosylation Analysis Services Market: Industry Trends and Global Forecasts, 2021-2030
4. Display Library Technologies and Affiliated Services Market: Industry Trends and Global Forecast, 2021-2030
5. Peptide Therapeutics Market: Industry Trends and Global Forecasts, 2021-2030

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at inforootsanalysis.com

Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnsonrootsanalysis.com

Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
Read more
Mikhail Telecomlife
12 months ago
МегаФон запустил специальный тариф для детей «МегаФон Kids»

https://telecomlife.ru/megafon-zapustil-spetsialnyj-tarif-dlya-detej-megafon-kids/
Ariel Soto
12 months ago
Steffan Joe
12 months ago
The biopreservation media providers market is projected to grow at an annualized rate of 23.57%.

Roots Analysis has done a detailed study on “Biopreservation Media Providers Market, 2021-2035”, covering key aspects of the market’s evolution and identifying potential future growth opportunities.

To order this 230+ page report, which features 90+ figures and 100+ tables, please visit this link

Key Market Insights
 Presently, over 60 players claim to be engaged in providing biopreservation media.
 Over 190 biopreservation media are presently offered across the globe, intended for the preservation of biological samples at different preservation conditions.
 In order to build a competitive advantage, companies are focused on steadily improving the characteristics of their media offerings.
 The growing interest is also evident from the rise in partnership activity, a relatively larger proportion of the deals were signed by companies based in the US.
 Driven by the rising approval of temperature sensitive products, the market for biopreservation media providers is poised to grow at an annualized rate of 23.57%, till 2035.
 The projected market opportunity is likely to be well distributed across different end users, biological samples, packaging formats and key geographical regions.

For additional details, please visit
https://www.rootsanalysis.com/reports/biopreservation-media-providers-market.html

Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY
2.1. Chapter Overview

3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Biopreservation
3.3. Type of Biopreservation
3.3.1. Hypothermic Preservation
3.3.2. Cryopreservation

3.4. Applications of Biopreservation Media
3.5. Benefits and Limitations of Biopreservation Media
3.6. Concluding Remarks

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Biopreservation Media Providers: Service Providers Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Type of Company
4.2.4. Analysis by Location of Headquarters

4.3. Biopreservation Media: Market Landscape
4.3.1. Analysis by Preservation Condition
4.3.2. Analysis by Type of Serum
4.3.3. Analysis by Type of Biological Sample
4.3.4. Analysis by Area of Application
4.3.5. Analysis by Type of Packaging Format
4.3.6. Analysis by Packaging Volume
4.3.7. Analysis by Product Price

5. KEY INSIGHTS
5.1. Chapter Overview
5.2. Analysis by Location of Headquarters (World Map Representation)
5.3. Analysis by Year of Establishment, Company Size, Number of Biopreservation Media Offered and Region (4D Bubble Chart)
5.4. Analysis by Preservation Condition and Area of Application (Treemap Representation)
5.5. Analysis by Company Size, Region, Preservation Condition, Type of Serum and Type of Biological Sample (Grid Representation)
5.6. Analysis by Minimum Packaging Volume and Minimum Price (Heat Map Representation)

6. COMPANY COMPETITIVENESS
6.1. Chapter Overview
6.2. Assumptions and Key Parameters
6.3. Methodology
6.4. Benchmarking of Product Portfolio Strength
6.5. Benchmarking of Partnership Activity
6.6. Biopreservation Media Providers: Company Competitiveness Analysis
6.6.1. Company Competitiveness Analysis: Very Small Companies
6.6.2. Company Competitiveness Analysis: Small Companies
6.6.3. Company Competitiveness Analysis: Mid-Sized Companies
6.6.4. Company Competitiveness Analysis: Large Companies

7. COMPANY PROFILES
7.1. Chapter Overview
7.2. BioLife Solutions
7.2.1. Company Overview
7.2.2. Recent Developments and Future Outlook

7.3. Cell Applications
7.3.1. Company Overview
7.3.2. Recent Developments and Future Outlook

7.4. HiMedia Laboratories
7.4.1. Company Overview
7.4.2. Recent Developments and Future Outlook

7.5. Merck
7.5.1. Company Overview
7.5.2. Recent Developments and Future Outlook

7.6. Thermo Fischer Scientific
7.6.1. Company Overview
7.6.2. Recent Developments and Future Outlook

7.7. United States Biological
7.7.1. Company Overview
7.7.2. Recent Developments and Future Outlook

7.8. ZenBio
7.8.1. Company Overview
7.8.2. Recent Developments and Future Outlook

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Biopreservation Media Providers: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.2.1. Analysis by Year and Type of Partnership
8.3.2.2. Analysis by Type of Partnership and Company Size

8.3.3. Analysis by Type of Partner
8.3.3.1. Analysis by Year of Partnership and Type of Partner
8.3.3.2. Analysis by Type of Partner and Type of Partnership
8.3.3.3. Analysis by Type of Partner and Company Size

8.3.4. Most Active Players: Analysis by Number of Partnerships
8.3.5. Regional Analysis
8.3.5.1. Local and International Deals
8.3.5.2. Intercontinental and Intracontinental Deals
8.3.5.3. Analysis by Location of Headquarters of Partner
8.3.5.4. Analysis by Location of Headquarters of Partner and Type of Partnership

9. BOWMAN CLOCK PRICING STRATEGY
9.1. Chapter Overview
9.2. Bowman Strategy Clock
9.2.1. Two Dimensions of Bowman Strategy Clock
9.2.2. Eight Positions on Bowman Strategy Clock

9.3. Roots Analysis Framework
9.3.1. Methodology
9.3.2. Theoretical Framework and Price Evaluation Hypothesis
9.3.3. Results and Interpretation
9.3.3.1. Bowman Clock Pricing Strategy Graphical Representation
9.3.3.2. Product Price Evaluation Matrix: Information on Preservation Condition
9.3.3.3. Product Price Evaluation Matrix: Information on Type of Serum
9.3.3.4. Product Price Evaluation Matrix: Information on Type of Biological Sample
9.3.3.5. Product Price Evaluation Matrix: Information on Minimum Packaging Volume
9.3.3.6. Product Price Evaluation
Read more
Steffan Joe
12 months ago
At-home blood collection and micro sampling devices market is projected to grow at a CAGR of 10.7 %.
Roots Analysis has done a detailed study on At-Home Blood Collection and Micro Sampling Devices market, 2021-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 190 page report, which features 95+ figures and 110+ tables, please visit https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html

Key Market Insights
 The ongoing COVID-19 pandemic has accelerated the pace at which the healthcare sector is evolving, thereby, spurring innovations that allow patients to collect blood samples at-home as well as monitor their health remotely
 Presently, close to 50 at-home blood collection and micro sampling devices are available / being developed; majority of the firms engaged in this domain are start ups or small companies located in the US
 Most of the at-home devices intended for collection of whole capillary blood are presently marketed; DBS technology, used for preparation of dried blood spot cards, has emerged as the most popular platform
 In pursuit of gaining a competitive edge, stakeholders are actively expanding their product portfolios and upgrading their devices, via incorporation of advanced features
 Over the years, the intellectual property related to blood collection devices has grown at a commendable pace, with majority of the patents being filed by industry players
 The growing interest of the stakeholders is also reflected from the recent rise in partnership activity; a significant proportion of the deals inked till date were focused on market expansion
 To support the ongoing innovation in this domain, private and public investors have made substantial capital investments, worth ~USD 650 million, in initiatives of various industry stakeholders
 Given the favourable increase in adoption of at-home blood collection and micro sampling devices during the COVID-19 pandemic, the market is anticipated to witness significant growth in the foreseen future

For more information, please visit https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of At-Home Blood Collection and Micro Sampling Devices
3.3. Applications of Blood Sampling and Testing
3.3.1. Complete Blood Count
3.3.2. Basic Metabolic Panel
3.3.3. Lipoprotein Panel
3.4. Types of Blood Sampling
3.4.1. Dried Blood Sampling
3.4.2. Wet Blood Sampling

3.5. Benefits of At-Home Blood Collection
3.6. Methods Used for At-Home Blood Collection
3.6.1. Fingerstick Method
3.6.2. Press Button Method
3.6.3. Heel-stick Method
3.7. Types of At-Home Blood Collection and Micro Sampling Devices
3.7.1. Dried Blood Spot Collection Kits
3.7.2. Microtainer Tubes

3.8. Future Perspectives

4. MARKET OVERVIEW
4. Market Overview
4.1. Chapter Overview
4.2. At-Home Blood Collection and Micro Sampling Devices: Overall Market Landscape
4.2.1. Analysis by Device Class
4.2.2. Analysis by Current Status of Development
4.2.3. Analysis by Regulatory Approvals / Certifications Received
4.2.4. Analysis by Type of Technology
4.2.5. Analysis by Device Usage
4.2.6 Analysis by Type of Sample
4.2.7. Analysis by Blood Sample State
4.2.8. Analysis by Volume of Sample Collected
4.2.9. Analysis by Puncture Site
4.2.10. Analysis by Method of Sample Collection
4.2.11. Analysis by Storage Temperature
4.2.12. Analysis by Application Area

4.3. At-Home Blood Collection and Micro Sampling Devices: List of Developers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Geography
4.3.4. Analysis by Year of Establishment, Company Size and Location of Headquarters
4.4. Most Active Players: Analysis by Number of Products

5. PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Input Parameters
5.3. Methodology
5.3.1. Product Competitiveness Analysis: North America
5.3.2. Product Competitiveness Analysis: Europe
5.3.3. Product Competitiveness Analysis: Asia-Pacific

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. EUROIMMUN
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. Everlywell
6.3.1. Company Overview
6.3.2. Product Portfolio
6.3.3. Recent Developments and Future Outlook

6.4. Labcorp
6.4.1. Company Overview
6.4.2. Product Portfolio
6.4.3. Recent Developments and Future Outlook

6.5. Labonovum
6.5.1. Company Overview
6.5.2. Product Portfolio
6.5.3. Recent Developments and Future Outlook

6.6. Lameditech
6.6.1. Company Overview
6.6.2. Product Portfolio
6.6.3. Recent Developments and Future Outlook

6.7. Quest Diagnostics
6.7.1. Company Overview
6.7.2. Product Portfolio
6.7.3. Recent Developments and Future Outlook

6.8. Spot On Sciences
6.8.1. Company Overview
6.8.2. Product Portfolio
6.8.3. Recent Developments and Future Outlook

6.9. Tasso
6.9.1. Company Overview
6.9.2. Product Portfolio
6.9.3. Recent Developments and Future Outlook

6.10. Weavr Health
6.10.1. Company Overview
6.10.2. Product Portfolio
6.10.3. Recent Developments and Future Outlook

6.11. YourBio Health
6.11.1. Company Overview
6.11.2. Product Portfolio
6.11.3. Recent Developments and Future Outlook

7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. At-Home Blood Collection and Micro Sampling Devices: Patent Analysis
7.2.1. Scope and Methodology
7.2.2. Analysis by Publication Year
7.2.3. Analysis by Publication Year and Type of Patent
7.2.4. Analysis by Geography
7.2.5. Analysis by CPC Symbols
7.2.6. Analysis by Emerging Focus Area
7.2.7. Most Active Players: Analysis by Num
Read more
Dasservicesinc
12 months ago
Accessories Of A #Vacuum Cleaner You Must Look For

Vacuum cleaners are useful devices that help you in cleaning your house thoroughly and with less effort. Nobody likes a filthy house but with the right vacuum cleaner, you easily get rid of dirt present beneath the carpet and on the floor. Some vacuum cleaners don’t have the capability to clean dirt from surfaces that are hard to reach.

Read more here:
Read more
Slaponn6 slapon
12 months ago
Polda Metro Jaya menggerebek sebuah ruko berlantai empat yang dijadikan kantor pinjaman online ilegal di kawasan Pantai Indah Kapuk Penjaringan Jakarta Utara pada Rabu malam

dari penggerebekan ini petugas
berhasil menangkap 99 orang satu
diantaranya merupakan manajer pinjol ilegal

rekam jejak percakapan
penagihan hingga intimidasi kepada para nasabah masih dapat terlihat pada puluhan perangkat komputer yang baru saja digunakan oleh para karyawan

dari hasil pemeriksaan awal diketahui
kantor pinjol ilegal yang mengoperasikan 14 aplikasi diantaranya Dana aman uang
Rodi pinjaman terjamin dana induk
go-kredit serta dana online

Hai hasil pemeriksaan polisi jari total
98 karyawan mayoritas adalah anak
dibawah umur.

mengimbau masyarakat orang tua kita, lihat banyak yang bekerja adalah
anak-anak yang masih dibawah umur ya Dan ini mereka memiliki ukuran terkait dan kegiatan yang dilaksanakan secara ilegal

jadi agar orangtua juga meningkatkan
pengawasan kepada anaknya agar tidak tersandung terkait dengan persoalan pinjol ilegal. pinjol ilegal ini beroperasi sejak Desember 2021 lalu dan tidak terdaftar di Otoritas Jasa Keuangan atau OJK
Read more
Mason Joe
12 months ago
The “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030”
To order this 170+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html

Key Inclusions
 A detailed review of the overall landscape of fragment-based drug discovery library and service providers along with the information on type of product (library and technology), type of service offered (fragment screening and fragment optimization), type of technique used (X-ray crystallography, nuclear magnetic resonance, surface plasmon resonance, and other screening techniques), other services offered (target identification / validation, hit identification, hit-to-lead / lead generation, lead optimization), and end user (industry, academia, and contract research organizations).
 Elaborate profiles of the companies providing libraries and services for fragment-based drug discovery (shortlisted on the basis of the service portfolio and number of fragment screening techniques offered). Each profile features a brief overview of the company, its financial information (if available), fragment-based library and service portfolio, information on other drug discovery services, recent developments and an informed future outlook.
 An analysis of the partnerships that have been established in the recent past, covering R&D collaborations, mergers and acquisitions, product development and commercialization agreements, commercialization agreements, distribution and supply agreements, product integration agreements, service agreements, and other relevant types of deals.
 A detailed analysis on acquisition targets, taking into consideration the historical trend of the activity of the companies that have acquired other firms since 2015, and offering a means for other industry stakeholders to identify potential acquisition targets.
 An insightful competitiveness analysis of fragment-based drug discovery library and service providers, based on supplier power (based on the years of experience of service provider) and key specifications, such as number of fragment libraries and number of screening techniques.
 An analysis highlighting the cost saving potential associated with the use of fragment-based drug discovery approach.
 Informed estimates of the existing market size and the future opportunity for fragment-based drug discovery library and services, over the next decade. Based on multiple parameters, such as annual number of drug discovery projects, outsourcing profile, and adoption of fragment-based drug discovery approach, we have provided informed estimates on the evolution of the market for the period 2020-2030.

The report features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
 Type of Screening Technique Used
 X-ray Crystallography
 Nuclear Magnetic Resonance
 Surface Plasmon Resonance
 Other Screening Techniques

 Type of Service Offered
 Library Screening
 Fragment Screening
 Fragment Optimization

 End User
 Industry Players
 Non-Industry Players

 Key geographical regions
Press Release: Variation 4 (Format 5)

 North America (US and Canada)
 Europe (UK, France, Germany, Spain, Italy, and rest of Europe)
 Asia-Pacific (China, Japan, India, and rest of Asia-Pacific / rest of the world)

The report also features inputs from eminent industry stakeholders, according to whom the fragment-based approach significantly simplifies the drug discovery process. The report includes detailed transcripts of discussions held with the following experts:
 Jean-Yves Ortholand (Co-founder and Chief Executive Officer, Edelris)
 Björn Walse (Chief Executive Officer, SARomics Biostructures)

To request sample pages, please visit this - https://www.rootsanalysis.com/reports/309/request-sample.html

Key Questions Answered
 Who are the leading players in the fragment-based drug discovery library and services market?
 What are the key biophysical techniques used by service providers for screening fragment libraries and lead optimization?
 Which types of partnership models are commonly adopted by stakeholders in this domain?
 What is the likely cost-saving opportunity associated with the use of fragment-based drug discovery?
 How is the current and future market opportunity likely to be distributed across key market segments?

You may also be interested in the following titles:
1. DNA-Encoded Libraries: Platforms and Services Market
2. Antibody Discovery: Services and Platforms Market (2nd Edition), 2018-2028
3. In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and Vectors), 2020-2030 (Including Structure Based Drug Discovery, Fragment Based Drug Discovery, Ligand Based Drug Discovery, Target Based Drug Discovery, Interface Based Drug Discovery Approaches)

Contact Us:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudharyrootsanalysis.com
Read more
Mason Joe
12 months ago
Around 40 players claim to offer both libraries and technologies
According to experts in this field, fragment-based drug discovery solutions have facilitated the identification of viable pharmacological leads against otherwise hard to target biomolecules. In fact, many service provider companies are offering fragment libraries and support to the medical research community in order to develop an appropriate intervention to treat the illness caused by the SARS-CoV-2 virus.

To order this 170+ page report, which features 55+ figures and 80+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html

The USD 1.6 billion (by 2030) financial opportunity within the fragment-based drug discovery market has been analyzed across the following segments:
 Type of Screening Technique Used
 X-ray Crystallography
 Nuclear Magnetic Resonance
 Surface Plasmon Resonance
 Other Screening Techniques

 Type of Service Offered
 Library Screening
 Fragment Screening
 Fragment Optimization

 End User
 Industry Players
 Non-Industry Players

 Key geographical regions
 North America (US and Canada)
 Europe (UK, France, Germany, Spain, Italy, and rest of Europe)
 Asia-Pacific (China, Japan, India, and rest of Asia-Pacific / rest of the world)

The “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030 report features the following companies, which we identified to be key players in this domain:
 2bind
 Charles River Laboratories
 ChemAxon
 ComInnex
 Creative Biolabs
 Creative Biostructure
 CRELUX
 Domainex
 Evotec
 Red Glead Discovery
 SARomics Biostructures
 Shanghai ChemPartner
 Sygnature Discovery
 Vernalis Research

Table of Contents

Press Release: Variation 3 (Format 4)

1. Preface

2. Executive Summary

3. Introduction

4. Current Market Landscape

5. Company Profiles: Fragment-based Drug Discovery Library and Service Providers

6. Partnerships and Collaborations

7. Key Acquisition Targets

8. Company Competitiveness Analysis

9. Cost Saving Analysis

10. Market Forecast and Opportunity Analysis

11. Executive Insights

12. Concluding Remarks

13. Appendix 1: Tabulated Data

14. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudharyrootsanalysis.com
Read more

Nothing found!

Sorry, but we could not find anything in our database for your search query {{search_query}}. Please try again by typing other keywords.